Financial Instruments (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Fair Value Disclosures [Abstract] |
|
| Summary of Marketable Securities Measured at Fair Value on a Recurring Basis |
The following tables summarize our cash, cash equivalents, and marketable securities measured at fair value on a recurring basis (in millions):
| | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | Cash | | | | | | $ | 12,407 | | Cash equivalents: | | | | | | | Money market funds | | $ | 8,154 | | | $ | 0 | | | $ | 8,154 | | Time deposits | | 0 | | | 2,081 | | | 2,081 | | | Government bonds | | 0 | | | 746 | | | 746 | | | Corporate debt securities | | 0 | | | 78 | | | 78 | | Total cash and cash equivalents | | 8,154 | | | 2,905 | | | 23,466 | | Marketable securities: | | | | | | | Marketable equity securities(1) | | 4,708 | | 105 | | 4,813 | Time deposits | | 0 | | | 136 | | | 136 | | | Government bonds | | 0 | | 28,709 | | 28,709 | | Corporate debt securities | | 0 | | 21,116 | | 21,116 | | Mortgage-backed and asset-backed securities | | 0 | | 17,417 | | 17,417 | Total marketable securities | | 4,708 | | | 67,483 | | | 72,191 | | | Total | | $ | 12,862 | | | $ | 70,388 | | | $ | 95,657 | |
(1)The long-term portion of marketable equity securities (subject to long-term lock-up restrictions) of $266 million as of December 31, 2024 is included within other non-current assets. | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | Cash | | | | | | $ | 15,305 | | Cash equivalents: | | | | | | | | Money market funds | | $ | 11,349 | | | $ | 0 | | | $ | 11,349 | | | Time deposits | | 0 | | | 3,353 | | | 3,353 | | | Government bonds | | 0 | | | 602 | | | 602 | | | Corporate debt securities | | 0 | | | 99 | | | 99 | | Total cash and cash equivalents | | 11,349 | | | 4,054 | | | 30,708 | | Marketable securities: | | | | | | | Marketable equity securities | | 4,402 | | 1,911 | | 6,313 | | Time deposits | | 0 | | | 0 | | | 0 | | | Government bonds | | 0 | | 50,549 | | 50,549 | | Corporate debt securities | | 0 | | 21,565 | | 21,565 | | Mortgage-backed and asset-backed securities | | 0 | | 17,708 | | 17,708 | Total marketable securities | | 4,402 | | | 91,733 | | | 96,135 | | | Total | | $ | 15,751 | | | $ | 95,787 | | | $ | 126,843 | |
|
| Schedule of Investments by Maturity Date |
The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates (in millions): | | | | | | | As of December 31, 2025 | | Due in 1 year or less | $ | 26,735 | | | Due in 1 year through 5 years | 37,001 | | | Due in 5 years through 10 years | 12,769 | | | Due after 10 years | 13,317 | | | Total | $ | 89,822 | |
|
| Schedule of Available-for-Sale Debt Securities |
The following tables present fair values and gross unrealized gains and losses recorded to AOCI, less any expected credit losses, aggregated by investment category (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 2,217 | | | $ | 0 | | | $ | 0 | | | $ | 2,217 | | | Government bonds | | 27,551 | | 83 | | | (214) | | | 27,420 | | | Corporate debt securities | | 18,300 | | | 79 | | | (222) | | | 18,157 | | | Mortgage-backed and asset-backed securities | | 14,437 | | | 63 | | | (385) | | | 14,115 | | Total investments with fair value change reflected in other comprehensive income | | $ | 62,505 | | | $ | 225 | | | $ | (821) | | | $ | 61,909 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 3,353 | | | $ | 0 | | | $ | 0 | | | $ | 3,353 | | | Government bonds | | 49,087 | | 443 | | | (26) | | | 49,504 | | | Corporate debt securities | | 18,346 | | | 242 | | | (32) | | | 18,556 | | | Mortgage-backed and asset-backed securities | | 14,337 | | | 174 | | | (128) | | | 14,383 | | Total investments with fair value change reflected in other comprehensive income | | $ | 85,123 | | | $ | 859 | | | $ | (186) | | | $ | 85,796 | |
|
| Schedule of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value |
The following tables present fair values and gross unrealized losses recorded to AOCI, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | Less than 12 Months | | 12 Months or Greater | | Total | | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 11,119 | | | $ | (126) | | | $ | 2,576 | | | $ | (88) | | | $ | 13,695 | | | $ | (214) | | | Corporate debt securities | 4,228 | | | (17) | | | 6,838 | | | (168) | | | 11,066 | | | (185) | | | Mortgage-backed and asset-backed securities | 5,222 | | | (106) | | | 3,813 | | | (279) | | | 9,035 | | | (385) | | | Total | $ | 20,569 | | | $ | (249) | | | $ | 13,227 | | | $ | (535) | | | $ | 33,796 | | | $ | (784) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Less than 12 Months | | 12 Months or Greater | | Total | | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 4,230 | | | $ | (9) | | | $ | 1,174 | | | $ | (17) | | | $ | 5,404 | | | $ | (26) | | | Corporate debt securities | 915 | | | 0 | | | 2,429 | | | (24) | | | 3,344 | | | (24) | | | Mortgage-backed and asset-backed securities | 1,377 | | | (4) | | | 3,035 | | | (124) | | | 4,412 | | | (128) | | | Total | $ | 6,522 | | | $ | (13) | | | $ | 6,638 | | | $ | (165) | | | $ | 13,160 | | | $ | (178) | |
|
| Schedule of Gains and Losses on Investments |
The following table summarizes gains and losses for debt securities, reflected as a component of OI&E (in millions): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | Unrealized gain (loss) on fair value option debt securities | $ | 386 | | | $ | 30 | | | $ | 254 | | | Gross realized gain on debt securities | 182 | | | 482 | | | 572 | | | Gross realized loss on debt securities | (1,833) | | | (1,553) | | | (316) | | (Increase) decrease in allowance for credit losses | 50 | | | (2) | | | 30 | | | Total gain (loss) on debt securities recognized in other income (expense), net | $ | (1,215) | | | $ | (1,043) | | | $ | 540 | |
Gains and losses (including impairments), net, for equity securities included in OI&E are summarized below (in millions): | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | 2023 | | 2024 | | 2025 | Gross unrealized gain on non-marketable equity securities accounted for under the measurement alternative | | $ | 1,806 | | | $ | 5,582 | | | $ | 22,666 | | Gross unrealized loss (including impairments) on non-marketable equity securities accounted for under the measurement alternative | | (2,894) | | | (2,210) | | | (1,271) | | Unrealized net gain (loss) on non-marketable equity securities accounted for under the measurement alternative | | (1,088) | | | 3,372 | | | 21,395 | | Unrealized net gain (loss) on marketable and other equity securities | | 790 | | | 156 | | | 1,907 | | Realized net gain (loss) on marketable and non-marketable equity securities sold during the period | | 690 | | | 186 | | | 778 | | Total gain (loss) on equity securities in other income (expense), net (1) | | $ | 392 | | | $ | 3,714 | | | $ | 24,080 | | (1) Excludes income (loss) and impairment from equity method investments. Refer to Note 7 for further details.
|
| Summary of Non-Marketable Securities |
The carrying values for non-marketable securities are summarized below (in millions):
| | | | | | | | | | | | | | | As of December 31, | | | 2024 | | 2025 | Non-marketable securities: | | | | | Total initial cost of non-marketable equity securities accounted for under the measurement alternative | | $ | 20,940 | | | $ | 28,429 | | Cumulative upward adjustments | | 22,709 | | | 44,485 | | Cumulative downward adjustments (including impairments) | | (8,431) | | | (8,820) | | Carrying value of non-marketable equity securities accounted for under the measurement alternative | | 35,218 | | | 64,094 | | Equity method investments and other | | 2,764 | | | 4,593 | | Total non-marketable securities | | $ | 37,982 | | | $ | 68,687 | |
|
| Schedule of Gross Notional Amounts of Derivative Instruments |
The gross notional amounts of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | As of December 31, | | 2024 | | 2025 | | | | | | Derivatives designated as hedging instruments: | | | | Foreign exchange contracts | | | | | Cash flow hedges | $ | 20,315 | | | $ | 23,852 | | | Fair value hedges | $ | 1,562 | | | $ | 0 | | | Net investment hedges | $ | 6,986 | | | $ | 14,203 | | | Derivatives not designated as hedging instruments: | | | | Foreign exchange contracts | $ | 44,227 | | | $ | 56,085 | | Credit derivatives(1) | $ | 0 | | | $ | 16,940 | | | Other contracts | $ | 15,082 | | | $ | 15,900 | |
(1) Notional amounts for credit derivatives are the backstop obligations related to certain third-party data center leases and represent the maximum potential amount of future payments that could be required in the event of certain default scenarios over remaining agreement periods of up to 15 years. In the event we are required to make payments under certain backstop obligations, we may receive equity in or cash payments from certain counterparties, the amounts for which are not reflected in the notional amounts for credit derivatives. See Note 5 for further details.
|
| Schedule of Derivative Instruments |
The fair values of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | As of December 31, 2025 | | | Assets(1) | | Liabilities(2) | | Assets(1) | | Liabilities(2) | | Derivatives designated as hedging instruments: | | | | | | | | | Foreign exchange contracts | $ | 1,054 | | | $ | 0 | | | $ | 316 | | | $ | 197 | | | | | | | | | | | Derivatives not designated as hedging instruments: | | | | | | | | | Foreign exchange contracts | 200 | | | 593 | | | 92 | | | 84 | | | Other contracts | 474 | | | 19 | | | 324 | | | 98 | | Total derivatives not designated as hedging instruments | 674 | | | 612 | | | 416 | | | 182 | | Total | $ | 1,728 | | | $ | 612 | | | $ | 732 | | | $ | 379 | |
(1) Derivative assets are recorded as other current and non-current assets. (2) Derivative liabilities are recorded as accrued expenses and other liabilities, current and non-current.
|
| Schedule of Gain (Loss) on Derivative Instruments |
The gains (losses) on derivatives and non-derivative financial instruments in cash flow hedging and net investment hedging relationships recognized in other comprehensive income are summarized below (in millions): | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2023 | | 2024 | | 2025 | Cash flow hedging relationship: | | | | | | Foreign exchange and other contracts | | | | | | | Amount included in the assessment of effectiveness | $ | 90 | | | $ | 857 | | | $ | (978) | | | Amount excluded from the assessment of effectiveness | 84 | | | 77 | | | (45) | | Net investment hedging relationship: | | | | | | Amounts included in the assessment of effectiveness | | | | | | Foreign exchange contracts | (287) | | | 223 | | | (765) | | Foreign currency-denominated debt | 0 | | | 0 | | | (393) | | Amounts excluded from the assessment of effectiveness | | | | | | | Foreign exchange contracts | 0 | | | 0 | | | 11 | | | Total | $ | (113) | | | $ | 1,157 | | | $ | (2,170) | |
The table below presents the gains (losses) of derivatives included on the Consolidated Statements of Income: (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2023 | | 2024 | | 2025 | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | Total amounts included on the Consolidated Statements of Income | $ | 307,394 | | | $ | 1,424 | | | $ | 350,018 | | | $ | 7,425 | | | $ | 402,836 | | | $ | 29,787 | | | | | | | | | | | | | | | Effect of cash flow hedges: | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | | Amount included in the assessment of effectiveness | 213 | | | 0 | | | 174 | | | 0 | | | (233) | | | 0 | | Amount excluded from the assessment of effectiveness | 24 | | | 0 | | | 37 | | | 0 | | | 107 | | | 0 | | | Effect of fair value hedges: | | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | | Hedged items | 0 | | | 59 | | | 0 | | | (59) | | | 0 | | | (9) | | Amount included in the assessment of effectiveness | 0 | | | (59) | | | 0 | | | 58 | | | 0 | | | 9 | | | Amount excluded from the assessment of effectiveness | 0 | | | 15 | | | 0 | | | 13 | | | 0 | | | 1 | | | Effect of net investment hedges: | | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | | Amount excluded from the assessment of effectiveness | 0 | | | 187 | | | 0 | | | 137 | | | 0 | | | 189 | | | Effect of non-designated hedges: | | | | | | | | | | | | | Foreign exchange contracts | 0 | | | 7 | | | 0 | | 335 | | | 0 | | | 445 | | | Other contracts | 0 | | | 53 | | | 0 | | | 174 | | | 0 | | | (148) | | | Total gains (losses) | $ | 237 | | | $ | 262 | | | $ | 211 | | | $ | 658 | | | $ | (126) | | | $ | 487 | |
|
| Schedule of Offsetting Assets |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | | $ | 1,776 | | | $ | (48) | | | $ | 1,728 | | | $ | (516) | | | $ | (721) | | | $ | 491 | | | Derivatives liabilities | | $ | 660 | | | $ | (48) | | | $ | 612 | | | $ | (516) | | | $ | (9) | | | $ | 87 | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
(1) The balances as of December 31, 2024 and 2025 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|
| Schedule of Offsetting Liabilities |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | | $ | 1,776 | | | $ | (48) | | | $ | 1,728 | | | $ | (516) | | | $ | (721) | | | $ | 491 | | | Derivatives liabilities | | $ | 660 | | | $ | (48) | | | $ | 612 | | | $ | (516) | | | $ | (9) | | | $ | 87 | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
(1) The balances as of December 31, 2024 and 2025 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|